User profiles for Viviane D. Lima
 | Viviane Dias LimaBC Centre for Excellence in HIV/AIDS & University of British Columbia Verified email at bccfe.ca Cited by 14222 |
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time
VD Lima, R Harrigan, DR Bangsberg… - JAIDS Journal of …, 2009 - journals.lww.com
Objective: To characterize the impact of longitudinal adherence on survival in drug-naive
individuals starting currently recommended highly active antiretroviral therapy (HAART) …
individuals starting currently recommended highly active antiretroviral therapy (HAART) …
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy
Objective: To characterize the temporal changes in mortality and life expectancy among HIV-positive
individuals initiating antiretroviral therapy in British Columbia, Canada, from 1993 …
individuals initiating antiretroviral therapy in British Columbia, Canada, from 1993 …
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic
We developed a mathematical model using a multiple source of infection framework to
assess the potential effect of the expansion of highly active antiretroviral therapy (HAART) …
assess the potential effect of the expansion of highly active antiretroviral therapy (HAART) …
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based …
JSG Montaner, VD Lima, R Barrios, B Yip, E Wood… - The Lancet, 2010 - thelancet.com
Background Results of cohort studies and mathematical models have suggested that
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART
VD Lima, J Geller, DR Bangsberg, TL Patterson… - Aids, 2007 - journals.lww.com
Objective: To determine the impact of depressive symptoms on mortality among HIV/AIDS
patients first initiating HAART and the potential role of patient adherence as a confounder and …
patients first initiating HAART and the potential role of patient adherence as a confounder and …
Differential impact of adherence on long-term treatment response among naive HIV-infected individuals
Objectives: To examine the long-term impact of adherence on virologic, immunologic, and
dual response stratified by type of HAART regimen in treatment-naive patients starting HAART …
dual response stratified by type of HAART regimen in treatment-naive patients starting HAART …
[PDF][PDF] Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale‐up in the age of direct‐acting antivirals
Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs
(PWID) cannot be achieved by harm reduction interventions such as needle exchange and …
(PWID) cannot be achieved by harm reduction interventions such as needle exchange and …
[HTML][HTML] Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada
Objective To establish the reliability and validity of a shortened (10-item) depression scale
used among HIV-positive patients enrolled in the Drug Treatment Program in British Columbia…
used among HIV-positive patients enrolled in the Drug Treatment Program in British Columbia…
Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level
VD Lima, DR Bangsberg, PR Harrigan… - JAIDS Journal of …, 2010 - journals.lww.com
Objective: To model the effect of adherence and duration of viral suppression on the risk of
viral rebound. Methods: Viral rebound was defined as the first of at least two consecutive viral …
viral rebound. Methods: Viral rebound was defined as the first of at least two consecutive viral …
[HTML][HTML] Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as …
JSG Montaner, VD Lima, PR Harrigan, L Lourenço… - PloS one, 2014 - journals.plos.org
Background There has been renewed call for the global expansion of highly active antiretroviral
therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, …
therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, …
